An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said, highlighting the company’s lead in a competitive area of medical research and ...
Tag: CRSP
CRSP Stock: The First CRISPR Gene-Editing Drug Could Be Here Sooner Than You Think
Crispr Therapeutics (CRSP) said Tuesday it will begin asking the Food and Drug Administration to approve what would be the first-ever gene-editing treatment to hit the market using the CRISPR technolo...